Blue Owl Capital (NYSE:OWL) Price Target Raised to $26.00 at Keefe, Bruyette & Woods

Blue Owl Capital (NYSE:OWL - Get Free Report) had its price target increased by stock analysts at Keefe, Bruyette & Woods from $22.00 to $26.00 in a report released on Friday,Benzinga reports. The firm presently has a "market perform" rating on the stock. Keefe, Bruyette & Woods' price target would suggest a potential upside of 10.69% from the company's previous close.

A number of other research firms have also weighed in on OWL. JMP Securities reissued a "market outperform" rating and set a $27.00 price target on shares of Blue Owl Capital in a research report on Wednesday, December 4th. Piper Sandler increased their target price on shares of Blue Owl Capital from $23.00 to $25.00 and gave the stock an "overweight" rating in a research note on Friday, November 1st. Wells Fargo & Company raised their target price on shares of Blue Owl Capital from $23.00 to $25.00 and gave the company an "equal weight" rating in a research note on Thursday, December 12th. Evercore ISI increased their price objective on Blue Owl Capital from $21.00 to $22.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. Finally, UBS Group raised their price objective on Blue Owl Capital from $20.00 to $27.00 and gave the company a "buy" rating in a research note on Tuesday, October 22nd. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $23.56.

Blue Owl Capital Trading Up 1.7 %

NYSE OWL traded up $0.39 during trading hours on Friday, hitting $23.49. 8,598,932 shares of the company's stock were exchanged, compared to its average volume of 5,565,872. The stock has a 50-day simple moving average of $23.24 and a 200 day simple moving average of $19.84. The firm has a market cap of $35.08 billion, a price-to-earnings ratio of 138.18, a PEG ratio of 1.66 and a beta of 1.14. Blue Owl Capital has a 1-year low of $14.37 and a 1-year high of $25.03.

Blue Owl Capital (NYSE:OWL - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The company reported $0.20 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.20. Blue Owl Capital had a return on equity of 19.98% and a net margin of 4.95%. The business had revenue of $600.88 million for the quarter, compared to analyst estimates of $565.93 million. During the same quarter in the prior year, the company earned $0.16 earnings per share. On average, sell-side analysts anticipate that Blue Owl Capital will post 0.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Blue Owl Capital

Several large investors have recently made changes to their positions in the business. ORG Wealth Partners LLC bought a new position in Blue Owl Capital during the 3rd quarter valued at approximately $32,000. Family Firm Inc. purchased a new position in shares of Blue Owl Capital in the 2nd quarter worth about $40,000. Rothschild Investment LLC bought a new position in Blue Owl Capital in the 2nd quarter worth about $45,000. Wilmington Savings Fund Society FSB purchased a new stake in Blue Owl Capital during the 3rd quarter valued at about $138,000. Finally, Signaturefd LLC raised its holdings in Blue Owl Capital by 19.3% in the third quarter. Signaturefd LLC now owns 9,137 shares of the company's stock worth $177,000 after buying an additional 1,476 shares during the last quarter. 35.85% of the stock is currently owned by hedge funds and other institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.